(1) A relevant health practitioner may access and use the monitored medicines database for 1 or more of the following purposes:
(a) to inform decisions in relation to the prescription or supply of a monitored medicine to a person under the relevant health practitioner's care;
(b) to inform decisions in relation to the treatment or care of a person under the relevant health practitioner's care;
(c) to disclose information about a person under the relevant health practitioner's care to that person;
(d) to disclose information about a person under the relevant health practitioner's care to another health practitioner involved in the person's treatment or care;
(e) a purpose prescribed by regulation.
(2) The chief health officer must make the monitored medicines database available to a relevant health practitioner at no cost.